CHEK1 and GFPT1 as Potential Blood-Based Biomarkers for Colorectal Cancer

Habibah Faroque, Nur Soleha Aria, Nor Amira Muzilah, Hamid Ali Nagi Al-Jamal, Mohd Fadliyazid Ab. Rahim, Yasuhiro Nakamura, Hironobu Sasano, Abdullah Azmahani

Abstract


BACKGROUND: The checkpoint kinase 1 (CHEK1) and glutamine-fructose-6-phosphate aminotransferase 1 (GFPT1) genes have been reported to have a crucial role in carcinogenesis in colorectal cancer (CRC). However, their association with the pathogenesis of CRC remains unclear. This study was conducted to study the expression of CHEK1 and GFPT1 genes in adenoma and adenocarcinoma CRC patients’ whole blood samples compared to the healthy controls.

METHODS: A comparative cross‑sectional study to examine the expression of CHEK1 and GFPT1 genes were conducted in 6 colorectal adenoma and 6 colorectal adenocarcinoma patients along with 6 healthy controls. Blood samples were taken from subjects, and CHEK1 and GFPT1 genes were analyzed by using reverse transcription quantitative polymerase chain reaction (RT-qPCR).

RESULTS: CHEK1 gene expression in blood samples has the highest in adenoma patients meanwhile for the GFPT1 gene expression has the highest in adenocarcinoma patients. Higher CHEK1 gene expression were also found in adenoma patients compared to healthy controls (p=0.040) and adenocarcinoma patients (p=0.025). Besides, at the 5% level of significance, the median GFPT1 gene expression was higher in colorectal adenocarcinoma patients compared to colorectal adenoma patients and healthy controls.

CONCLUSION: CHEK1 and GFPT1 may function as potential regulators in adenoma and adenocarcinoma and measuring their expression might be a potential tool to determine the CRC progression and could be further explored as blood diagnostic biomarkers for CRC patients.

KEYWORDS: CHEK1, GFPT1, colorectal cancer, adenoma, adenocarcinoma


Full Text:

PDF

References


Riihimäki M, Hemminki A, Sundquist J, Hemminki K. Patterns of metastasis in colon and rectal cancer. Sci Rep. 2016; 6: 29765, CrossRef.

Coleman HG, Loughrey MB, Murray LJ, Johnston BT, Gavin AT, Shrubsole MJ, et al. Colorectal cancer risk following adenoma removal: a large prospective population-based cohort study. Cancer Epidemiol Biomarkers Prev. 2015; 24(9): 1373-80, CrossRef.

Mármol I, Sánchez-de-Diego C, Dieste AP, Cerrada E, Yoldi MJR. Colorectal carcinoma: A general overview and future perspectives in colorectal cancer. Int J Mol Sci. 2017; 18(1): 197, CrossRef.

Luminturahardjo W, Soeatmadji DW, Mintaroem K, Rahajoe P, Sandra F. N-cadherin as an important marker in colorectal cancer: An investigation of b-catenin and cadherin expressions of SW-480 and HCT-116 cell lines. Indones Biomed J. 2021; 13(3): 289-94, CrossRef.

Harjanti DA, Murtono C, Suryawinata K, Halim A, Wiryokusuma MF, Djitro TB. John Cunningham virus t-antigen expression on mild and severe dysplasia adenomatous polyp, low and high grade adenocarcinoma of the colon. Mol Cell Biomed Sci. 2019; 3(1): 7-12, CrossRef.

Li L, Shao M, Peng P, Yang C, Song S, Duan F, et al. High expression of GFAT1 predicts unfavorable prognosis in patients with hepatocellular carcinoma. Oncotarget. 2017; 8(12): 19205-17, CrossRef.

Fang Y, Yu H, Liang X, Xu J, Cai X. Chk1-induced CCNB1 overexpression promotes cell proliferation and tumor growth in human colorectal cancer. Cancer Biol Ther. 2014; 15(9): 1268-79, CrossRef.

Faroque H, Azmahani A, Othman MAI, Bakar NHA, Wan-Arfah N, Omar SZ, et al. GFAT1: A potential prognostic biomarker in colorectal cancer. Malaysian J Med Heal Sci. 2023; 19(3): 13-9, CrossRef.

Ministry of Health Malaysia. National Strategic Plan for Cancer Control Programme 2021-2025. Putrajaya; Ministry of Health Malaysia; 2021, article.

Waisberg J, Contim-Neto L, Oliveira MDSL, Matheus CDO, Nagashima CA, Goffi FS. Determination of carcinoembryonic antigen levels in peripheral and draining venous blood in patients with colorectal carcinoma. Arq Gastroenterol. 2004; 41(2): 88-92, CrossRef.

Hauptman N, Glavač D. Colorectal Cancer Blood-Based Biomarkers. Gastroenterol Res Pract. 2017; 2017: 2195361, CrossRef.

National Library of Medicine [Internet]. CHEK1 checkpoint kinase 1 [Homo sapiens (human)] [updated 2011 Oct; cited 2023 Aug 5]. Available from: https://www.ncbi.nlm.nih.gov/.

Zhang Y, Hunter T. Roles of Chk1 in cell biology and cancer therapy. Int J Cancer. 2014; 134(5): 1013-23, CrossRef.

Duffy MJ. Use of biomarkers in screening for cancer. Adv Exp Med Biol. 2015; 867: 27-39, CrossRef.

Wu M, Pang JS, Sun Q, Huang Y, Hou JY, Chen G, et al. The clinical significance of CHEK1 in breast cancer: a high-throughput data analysis and immunohistochemical study. Int J Clin Exp Pathol. 2019; 12(1): 1-20, PMID.

Ke ZY, Fu T, Wang XC, Xuan M, Yin HH, Zhou JP, et al. CHK1 inhibition overcomes gemcitabine resistance in non-small cell lung cancer cell A549 [Internet]. Research Square. 2022; 2022: PPR542618, CrossRef.

Tan Z, Chen M, Wang Y, Peng F, Zhu X, Li X, et al. CHEK1: A hub gene related to poor prognosis for lung adenocarcinoma. Biomark Med. 2022; 16(2): 83-100, CrossRef.

Lam C, Low JY, Tran PT, Wang H. The hexosamine biosynthetic pathway and cancer: Current knowledge and future therapeutic strategies. Cancer Lett. 2021; 503: 11-8, CrossRef.

Yang C, Peng P, Li L, Shao M, Zhao J, Wang L, et al. High expression of GFAT1 predicts poor prognosis in patients with pancreatic cancer. Sci Rep. 2016: 6: 39044, CrossRef.

Li L, Shao M, Peng P, Yang C, Song S, Duan F, et al. High expression of GFAT1 predicts unfavorable prognosis in patients with hepatocellular carcinoma. Oncotarget. 2017; 8(12): 19205-17, CrossRef.

Li D, Guan M, Cao X, Qiang Zha Z, Zhang P, Xiang H, et al. GFPT1 promotes the proliferation of cervical cancer via regulating the ubiquitination and degradation of PTEN. Carcinogenesis. 2022; 43(10): 969-79, CrossRef.

Saad H, Taib W, Ismail I, Johan M, Al‑Wajeeh A, Al‑jamal H. Reduced hepcidin expression enhances iron overload in patients with HbE/β‑thalassemia: Α comparative cross‑sectional study. Exp Ther Med. 2021; 22(6): 1402,

Dai W, Dierschke SK, Toro AL, Dennis MD. Consumption of a high fat diet promotes protein O-GlcNAcylation in mouse retina via NR4A1-dependent GFAT2 expression. Biochim Biophys Acta Mol Basis Dis. 2018; 1864(12): 3568-76, CrossRef.

Pabla N, Bhatt K, Dong Z. Checkpoint kinase 1 (Chk1)-short is a splice variant and endogenous inhibitor of Chk1 that regulates cell cycle and DNA damage checkpoints. Proc Natl Acad Sci USA. 2012; 109(1): 197-202, CrossRef.

Gaillard H, García-Muse T, Aguilera A. Replication stress and cancer. Nat Rev Cancer. 2015; 15(5): 276-89, CrossRef.

Fadaka AO, Bakare OO, Sibuyi NRS, Klein A. Gene expression alterations and molecular analysis of CHEK1 in solid tumors. Cancers. 2020; 12(3): 662, CrossRef.

Gong Y, Qian Y, Luo G, Liu Y, Wang R, Deng S, et al. High GFPT1 expression predicts unfavorable outcomes in patients with resectable pancreatic ductal adenocarcinoma. World J Surg Oncol. 2021; 19(1): 35, CrossRef.

Jia C, Li H, Fu D, Lan Y. GFAT1/HBP/O-GlcNAcylation Axis Regulates β-Catenin Activity to Promote Pancreatic Cancer Aggressiveness. Biomed Res Int. 2020; 2020: 1921609, CrossRef.

Hidayah N, Yustisia I, Natzir R, Hafiyani L, Ilhamuddin I, Aswad H, et al. Viability, migration rate, and mRNA expression of GLUT5, GLUT7, GLUT11 in WiDr colorectal cancer cell line. Indones Biomed J. 2023; 15(5): 304-10, CrossRef.

Jiang Y, Huang T, Chen L, Gao YF, Cai Y, Chou KC. Signal propagation in protein interaction network during colorectal cancer progression. Biomed Res Int. 2013; 2013: 287019, CrossRef.

Alisson-Silva F, Freire-de-Lima L, Donadio JL, Lucena MC, Penha L, Sá-Diniz JN, et al. Increase of O-glycosylated oncofetal fibronectin in high glucose-induced epithelial-mesenchymal transition of cultured human epithelial cells. PLoS One. 2013; 8(4): e60471, CrossRef.

Wulandari F, Hanifa M. Integrative Bioinformatics Reveals the Lactate Dehydrogenase B (LDHB) Significance in Colon Adenocarcinoma. Mol Cell Biomed Sci. 2023; 7(2): 98-108, CrossRef.




DOI: https://doi.org/10.18585/inabj.v15i6.2708

Copyright (c) 2023 The Prodia Education and Research Institute

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

 

Indexed by:

                  

               

                   

 

 

The Prodia Education and Research Institute